期刊文献+

HLA-DRB1基因全长序列分子克隆及测序方法的建立 被引量:1

Establishment of the assay for sequencing and cloning full-length HLA-DRB1 gene
原文传递
导出
摘要 目的建立可靠的HLA-DRB1等位基因全长序列的分子克隆和测序方法。方法设计、合成HLA-DRB1基因全长序列PCR引物和探索PCR反应体系,采用长距离PCR技术,对10份经PCR产物直接测序、基因型已知的标本,扩增HLA-DRB1基因5'-UTR区、6个外显子、5个内含子和3'-UTR区,全长约11 kb。PCR产物纯化后作长片段分子克隆,筛选阳性克隆,提取质粒DNA,采用自行设计的测序引物测序。结果 PCR扩增获得了特异性目的片段,克隆测序后获得了全部10种等位基因的全长序列。将HLA-DRB1等位基因全长序列划分为9个亚区,群体遗传学分析发现第2外显子的平均核苷酸变异率(π)8.653%,高于其他外显子,并且非同义突变率(dn)9.029%大于同义突变率(ds)7.846%。第5内含子的平均核苷酸变异率高达13.690%,DRB1*09∶01∶02和DRB1*07∶01∶01∶02这2个等位基因第5内含子的序列与其他等位基因序列差别较大。结论采用HLA-DRB1基因全长序列分子克隆及测序方法获得了HLA-DRB1基因各亚区多态性分布特点等基础资料。 Objective To establish the reliable assay for cloning and sequencing full-length HLA-DRB1 al- leles. Methods The genomie full-length HIA-DRB1 gene covering 5 '-UTR through 3'-UTR with 11 kb was amplified using the self-designed PCR primer pairs by long template PCR, purified PCR products was cloned into the pMD19-Tsimple plus- mid vector and the plasmid DNA isolated from positive clones was subjected to haplotype sequencing. A total of 10 samples having been previously-genotyped by PCR sequence based typing were subjected to full length HLA-DRB1 allele cloning and haplotype sequencing. Results The specific target fragment of HLA-DRB1 gene could be amplified and the full-length se- quences of 10 HLA-DRB1 alleles covering from 5 '-UTR to 3'-UTR region could be obtained using our method. The further population genetic study indicated that the π value of exon 2 (8. 653% ) was much more than the other exonic sub-regions, moreover,the dn value (9. 029% ) of exon 2 was more than that of ds(7. 846% ). The most polymorphic sub-region was in- tron 5 with π value of 13. 690% ,the sequences of intron 5 for DRB1 * 09:01 : 02 and DRB1 * 07:01 : 01 : 02 were distinct from other alleles. Conduslon The technique of cloning and sequencing full-length HIA-DRB1 gene has been established and the polymorphisms of DRB1 sub-regions and its characterizations has been elucidated.
出处 《中国输血杂志》 CAS CSCD 北大核心 2012年第6期538-542,共5页 Chinese Journal of Blood Transfusion
基金 广东省自然科学基金资助项目(9451803501004124)
关键词 HLA-DRB1基因 全长序列 克隆 单体型测序 HLA-DRB1 Full-length sequence Cloning Haplotype sequencing
  • 相关文献

参考文献12

  • 1Kappes D, Strominger JL. Human class II major histocompatibility complex genes and proteins. Ann Rev Biochem, 1988,57 (10): 991-1028.
  • 2Jang HW,Shin HW,Cho HJ,et al. Identification of HLA-DRB1 al- leles associated with Graves'disease in Koreans by sequence-based typing. Immunol Invest, 2011,40 ( 2 ) : 172-182.
  • 3Robinson J, Waller MJ, Parham P, et al. IMGT/HLA and IMGT MHC:sequence databases for the study of the major histocompati1 bility complex. Nucleic Acids Res,2003,31 ( 1 ) :311-314. |.
  • 4Rozas J, Snchez-DelBarrio JC, Messeguer X, et al. DNaSP, DNA polymorphism analyses by the coalescent and other methods. Bioin- formatics ,2003,19 ( 18 ) :2496-2497.
  • 5邓志辉,徐筠娉,高素青,李大成,喻琼,苏宇清,曾健强,杨宝成.HLA-Cw基因全长序列分子克隆及测序方法的建立[J].中华医学遗传学杂志,2009,26(3):258-262. 被引量:11
  • 6von Salom6 J, Gyllensten U, BergstrSm TF. Full-length sequence a- nalysis of the HLA-DRB1 locus suggests a recent origin of alleles. lmmunogenetics ,2007,59 (4) :261-271.
  • 7Hughes AL, Yeager M. Natural selection at major histocompatibility complex loci of vertebrates. Annu Rev C, enet, 1998,32: ( 12)415-435.
  • 8Gorski J, Mach B. Polymorphism of human Ia antigens :gene conver-sion between two DR beta loci results in a new HEA-D/DR speci- ficity. Nature, 1986,322 ( 6074 ) : 67-70.
  • 9Spurgin LG,van Oosterhout C,lllem JC,et al. Gene conversion rapidly generates major histocompatibility complex diversity in recently founded bird populations. Mol Ecol,2011,20(24) :5213-5225.
  • 10O'huigin C, Kulkami S, Xu Y, et al. The molecular origin and con- sequences of escape from miRNA regulation by HLA-C alleles. Am J Hum Genet. 2011,89 ( 3 ) :424-431.

二级参考文献11

  • 1Colonna M, Brooks EG, Ferrara GB, et al. Generation of allospecifie natural killer cells by stimulation across a polymorphism of HLA-C. Science, 1993, 260 : 1121-1124.
  • 2Flores AC, Marcos CY, Paladino N, et al. KIR receptors and HLA-C in the maintenance of pregnancy. Tissue Antigens, 2007, 69(Suppl 1): 112-113.
  • 3Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class Ⅰ and class Ⅱ high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood, 2004, 104: 1923-1930.
  • 4Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versushost disease and implication for its molecular mechanism. Blood, 2007, 110: 2235-2241.
  • 5Thompson JD, Gibson TJ, Plewniak F, et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequences alignment aided by quality analysis tools. Nucleic Acids Res, 1997, 25 : 4876-4882.
  • 6van den Elsen PJ, Gobin SJ, van Eggermond MC, et al. Regulation of MHC class Ⅰ and Ⅱ gene transcription differences and similarities. Immunogenetics, 1998, 48: 208-221.
  • 7Cox ST, Ogilvie H, Bohan EM, et al. Sequence of two new HLA- Cw alleles: HLA-Cw * 0313 and HLA-Cw * 1208. Tissue Antigens, 2002, 59 : 49-51.
  • 8Cox ST, McWhinnie AJ, Robinson J, et al. Cloning and sequencing full-length HLA-B and -C genes. Tissue Antigens, 2003, 61:20-48.
  • 9Hong WG, Chen SW, Shao HW, et al. HLA class Ⅰ polymorphism in Mongolian and Hui ethnic groups from northern China. Hum Immunol, 2007, 68 : 439-448.
  • 10田伟,李立新,周劲峰,郭实士.中国南方汉族人群HLA-Cw座位基因多态性分析[J].中华微生物学和免疫学杂志,2002,22(1):95-98. 被引量:26

共引文献10

同被引文献16

  • 1鞠海英,刘亚珍,刘永茂,李勇.碘化钾与酚/氯仿提取外周血基因组DNA方法的比较[J].中国生物制品学杂志,2006,19(5):532-533. 被引量:12
  • 2Chen P, Lin J J, Lu C S, Ong C T, Hsieh P F, Yang C C, Tai C T, Wu S L, Lu C H, Hsu Y C, Yu H Y, Ro L S, Lu C T, Chu C C, Tsai J J, Su Y H, Lan S H, Sung S F, Lin S Y, Tsai P J, Liao H T, Lin Y H, Chen C H, Chung W H, Hung S I, Wu J Y, Chang C F, Chen L, Chen Y T, Shen C Y. New. Engl. J. Med., 2011, 364(12): 1126-1133.
  • 3Somkrua R, Eickman E E, Saokaew S, Lohitnavy M, Chaiyakunaptuk N. BMC Med. Genet., 2011, 12(1): 118.
  • 4Mallal S, Phillips E, Carosi G, Molina J M, Workman C, Toma?i? J, J?gel-Guedes E, Rugina S, Kozyrev O, Cid J F, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A. New. Engl. J. Med., 2008, 358(6): 568-579.
  • 5Pozzi S, Longo A, Ferrara G B. Tissue antigens, 1999, 53(3): 275-281.
  • 6Song Q X, Wei G J, Zhou G H. Food. Chem., 2014, 154: 78-83.
  • 7Song Q X, Jing H, Wu H P, Kajiyama T, Kambara H. Analyst, 2010, 135(6): 1315-1319.
  • 8Song Q X, Wu H P, Feng F, Zhou G H, Kajiyama T, Kambara H. Anal. Chem., 2010, 82(5): 2074-2081.
  • 9Zetterquist H, Olerup O. Hum. Immunol., 1992, 34(1): 64-74.
  • 10Ng J, Nurlay C K, Baxter‐Lowe L A, Chepak M, Cappe P A, Hagland J, KaKuraya D, Manes D, Rosner G, Schmeckpaper B, Yang S Y, Robert J, Hartzman. Tissue Antigens, 1993, 42(5): 473-479.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部